Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and a leading player in the domestic branded formulations market. Ranked #20 in the IPM, Eris has established a leading presence in its core cardio-metabolic franchise in just 17 years from inception.
Eris embarked on a remarkable journey in the Indian pharmaceutical industry 17 years ago, driven by a vision to make a meaningful impact in the management of chronic diseases and build a business model pivoted around specialist and super specialist doctors. Over the years, we have evolved into a formidable entity with leadership positions across key therapies and high prescription ranks across doctor specialties. We continue to focus on our engagement programmes aimed at facilitating the generation of actionable scientific evidence to enable clinicians to improve clinical outcomes as well as augmenting our Patient Care Initiatives by bringing cutting edge diagnostic facilities and subsequent treatment options. As we progress towards our third decade of existence, we are guided by our founding principles and poised to continue our legacy of excellence.
Our market engagement consists of two pillars – (i) Patient Care Initiatives (PCI), and (ii) India-Centric Studies. Through our PCI platform, we bring cutting edge diagnosis and monitoring technologies to patients. The insights from these interventions are immensely useful to our physicians in managing the health outcomes of their patients. Examples of such interventions include Ambulatory Blood Pressure Monitoring (ABPMs), Continuous Glucose Monitoring (CGMs), Holter Devices, Sleep Studies, etc.
Our second engagement pillar, India-centric Studies was born out of the imperative to generate and use India-centric data in the diagnosis and management of cardio-metabolic conditions. In FY21 the results of our first such study – The India Heart Study (IHS) – were published in the Journal of Hypertension, which is the official journal of the European Society of Hypertension. On the back of the success of the IHS, we recently concluded the India Diabetes Study (IDS), the results of which were published in April 2022 in the Public Library of Science (PLOS) journal.
FY24 marked a significant year as we put in place a platform to enter the injectables segment in India, an INR 35,000+ crore p.a. market opportunity. To this effect, in February 2024 we acquired a controlling equity in Swiss Parenterals, a dossier driven sterile injectable business with a product range of 190 unique molecules and a pipeline of 40+ new molecules. In March 2024* we announced the acquisition of Biocon’s India Branded Formulation business, thereby completing the second leg of our India Injectables strategy. The acquired business will add significant momentum to our organically built Insulin franchise with the addition of two Insulin power brands – Basalog and Insugen. The Critical Care division will serve as a great platform for us to jumpstart our India branded Injectables play through already established brands of Biocon as well as addition of new products from Swiss Parenterals pipeline of new and existing molecules. The acquisition also gave us an entry into the large and fast-growing segment of Oncology with a portfolio of monoclonal antibodies.
* The deal financial closure was on 2 April 2024.
Interested candidates may send their updated CVs at hr.guwahati@erislifesciences.com and can contact us at +918486039093
Whatsapp CV – 8510820220
Interview mode- Telephonic
JOB DETAILS:
- Department: QC,Warehouse,IPQA,Soft Gel
- Experience:2-11 years
- Qualification: 10th,ITI,12th,Bsc,bpharm,Mpharm,Msc
- Salary:₹Not Disclosed
Warehouse-Officer PM
- Experience required – 2 to 3 years
- Qualification – B.Sc. or any Bachelor’s Degree
Responsibility-FG Dispatch, PM Dispensing, RM/PM Handling
Quality Control-Officer RM
- Experience required – 2 to 3 years
- Qualification – B.Sc./M.Sc./B.Pharm/M.Pharm
Responsibility- Must Handle HPLC instrument
Quality Control-Officer/Senior Officer RM
- Experience required – 4 to 5 years
- Qualification – B.Sc.
Responsibility-PM Analysis, RM Analysis
Soft Gel-Encapsulation Operator
- Experience required – 10 to 11 years
- Qualification – 10th/12th/ITI
Responsibility – Must have experience in running Arbes Tools.
IPQA-Officer/Senior Officer
- Experience required – 3 to 6 years
- Qualification – B.Pharm/M.Pharm
Responsibility-Packing Shopfloor Activities, Manufacturing Shopfloor Activities.
For More JOB Updates Join Our Whatsapp Group Click Here
